The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 09, 2020

Filed:

Jun. 17, 2011
Applicants:

Lawrence M. Kauvar, San Francisco, CA (US);

Stote Ellsworth, Palo Alto, CA (US);

William Usinger, Lafayette, CA (US);

Krista M. Mccutcheon, Burlingame, CA (US);

Minha Park, Brisbane, CA (US);

BO Chen, Daly City, CA (US);

Ying-ping Jiang, Lafayette, CA (US);

Inventors:

Lawrence M. Kauvar, San Francisco, CA (US);

Stote Ellsworth, Palo Alto, CA (US);

William Usinger, Lafayette, CA (US);

Krista M. McCutcheon, Burlingame, CA (US);

Minha Park, Brisbane, CA (US);

Bo Chen, Daly City, CA (US);

Ying-Ping Jiang, Lafayette, CA (US);

Assignee:

TRELLIS BIOSCIENCE, LLC, Redwood City, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/42 (2006.01); C12N 5/10 (2006.01); C07K 16/10 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/1018 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract

Monoclonal antibodies and fragments thereof that are crossreactive with multiple clades of influenza virus including both Group 1 and Group 2 representatives are disclosed. These antibodies are useful in controlling influenza epidemics and pandemics as well as in providing prophylactic or therapeutic protection against seasonal influenza.


Find Patent Forward Citations

Loading…